WHO ICTRP trial
First-line catheter ablation for early treatment of Persistent (ongoing unless…
EUCTR2021-006614-37-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-006614-37-SE |
|---|---|
| Public title | First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study comparing isolation of pulmonary veins triggering AF using a Cryoballoon versus antiarrhythmic medication. |
| Scientific title | First-line cryoablation for early treatment of Persistent Atrial Fibrillation – a randomized study comparing early trigger isolation using the Cryoballoon versus antiarrhythmic medication. - CryoStopPersAF |
| Primary sponsor | Region Örebro |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Sweden |
| Conditions | Persistent symptomatic atrial fibrillation MedDRA version: 25.1 Level: LLT Classification code 10081865 Term: Cardiac catheter ablation System Organ Class: 100000004865 ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques… |
| Interventions | Trade Name: tambocor Pharmaceutical Form: Tablet Trade Name: multaq Pharmaceutical Form: Tablet Trade Name: rytmonorm Pharmaceutical Form: Tablet Trade Name: sotalol Pharmaceutical Form: Tablet |
| Registration date | Mar 14, 2022 |
| Target size | 220 |
| Secondary IDs | CryoStopPersAF |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: